share_log

Kunshan Kersen Science & TechnologyLtd (SHSE:603626 Investor Five-year Losses Grow to 42% as the Stock Sheds CN¥396m This Past Week

Kunshan Kersen Science & TechnologyLtd (SHSE:603626 Investor Five-year Losses Grow to 42% as the Stock Sheds CN¥396m This Past Week

崑山科森科技股份有限公司(上海證券交易所股票代碼:603626)上週股價下跌3.96億元人民幣,投資者五年期虧損增長至42%
Simply Wall St ·  04/23 08:04

For many, the main point of investing is to generate higher returns than the overall market. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may be questioning their investment in Kunshan Kersen Science & Technology Co.,Ltd. (SHSE:603626), since the last five years saw the share price fall 44%. And some of the more recent buyers are probably worried, too, with the stock falling 25% in the last year. The falls have accelerated recently, with the share price down 16% in the last three months. We note that the company has reported results fairly recently; and the market is hardly delighted. You can check out the latest numbers in our company report.

對於許多人來說,投資的要點是產生比整個市場更高的回報。但是,幾乎每個投資者都肯定會有表現過硬和表現不佳的股票。此時,一些股東可能會質疑他們對崑山科森科技有限公司的投資。, Ltd.(上海證券交易所代碼:603626),自過去五年股價下跌44%以來。一些最近的買家可能也感到擔憂,該股去年下跌了25%。最近跌勢加速,股價在過去三個月中下跌了16%。我們注意到,該公司最近公佈了業績;市場對此並不滿意。你可以在我們的公司報告中查看最新的數字。

If the past week is anything to go by, investor sentiment for Kunshan Kersen Science & TechnologyLtd isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

如果過去一週有意義的話,崑山科森科技有限公司的投資者情緒並不樂觀,所以讓我們看看基本面和股價之間是否存在不匹配的情況。

Kunshan Kersen Science & TechnologyLtd wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually desire strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

崑山科森科技有限公司在過去十二個月中沒有盈利,我們不太可能看到其股價與每股收益(EPS)之間存在很強的相關性。可以說,收入是我們的下一個最佳選擇。無利可圖的公司的股東通常希望強勁的收入增長。那是因爲如果收入增長可以忽略不計,而且從來沒有盈利,就很難確信一家公司能否實現可持續發展。

Over five years, Kunshan Kersen Science & TechnologyLtd grew its revenue at 7.6% per year. That's a fairly respectable growth rate. We doubt many shareholders are ok with the fact the share price has fallen 8% each year for half a decade. Clearly, the expectations from back then have not been satisfied. The lesson is that if you buy shares in a money losing company you could end up losing money.

在過去的五年中,崑山科森科技有限公司的收入以每年 7.6% 的速度增長。這是一個相當可觀的增長率。我們懷疑許多股東對股價在過去五年中每年下跌8%這一事實是否滿意。顯然,當時的期望並未得到滿足。教訓是,如果你購買一家虧損公司的股票,你最終可能會蒙受損失。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何隨着時間的推移而變化(點擊圖片了解確切的值)。

earnings-and-revenue-growth
SHSE:603626 Earnings and Revenue Growth April 23rd 2024
SHSE: 603626 收益和收入增長 2024 年 4 月 23 日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表的強度至關重要。可能值得一看我們關於其財務狀況如何隨着時間的推移而變化的免費報告。

A Different Perspective

不同的視角

While the broader market lost about 15% in the twelve months, Kunshan Kersen Science & TechnologyLtd shareholders did even worse, losing 25% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 7% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Kunshan Kersen Science & TechnologyLtd you should be aware of, and 1 of them is potentially serious.

儘管整個市場在十二個月中下跌了約15%,但崑山科森科技有限公司的股東表現甚至更糟,損失了25%(甚至包括股息)。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨7%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。一個很好的例子:我們發現了你應該注意的崑山科森科技有限公司的3個警告信號,其中一個可能很嚴重。

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論